Looking to push checkpoint efficacy, a quiet microbiome upstart bags $67M for clinical work

Microbiotica has some more funds to work with — $67 million more.

The quiet microbiome therapeutics spinout with 48 employees announced its Series B earlier this morning, which was co-led by Swedish investor Flerie Invest alongside Chinese multinational conglomerate Tencent. Other investors hopped onto the round, including new investor British...

Click to view original post